enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno OpportunityAccesswire • about 1 month ago
Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, March 21st at 12:00 PM ETIRVINE, CA / ACCESSWIRE / March 15, 2024 / enVVeno Medical Corporation...
Share to Feed
BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
97% of VenoValve Study Patients Showing Clinical Improvement at Six Months (as Measured by the Revised Venous Clinical Severity Score (rVCSS))74% of the Study Patients Showing Clinical Meaningful...
$46.4 million cash and investments on hand sufficient to fund current operations, including multiple value driving milestones, through the end of 2025Topline efficacy data for VenoValve(R) U.S...
IRVINE, CA / ACCESSWIRE / February 20, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ('enVVeno' or the 'Company'), a company setting new standards of care for the treatment of venous disease...
Gagnants
Le titre Clene (NASDAQ:CLNN) a augment mardi de 18,20% 0,50 dollars lors de la session after-market.
L'action Larimar Therapeutics (NASDAQ:LRMR) a augment de 14,41% 10 dollars.
Le...
With the business potentially at an important milestone, we thought we'd take a closer look at enVVeno Medical...